Page last updated: 2024-11-02

pamidronate and Menopause

pamidronate has been researched along with Menopause in 2 studies

Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonde, M1
Garnero, P1
Fledelius, C1
Qvist, P1
Delmas, PD1
Christiansen, C1
Reid, IR1
King, AR1
Alexander, CJ1
Ibbertson, HK1

Trials

1 trial available for pamidronate and Menopause

ArticleYear
Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
    Lancet (London, England), 1988, Jan-23, Volume: 1, Issue:8578

    Topics: Calcium; Clinical Trials as Topic; Diphosphonates; Female; Glucocorticoids; Humans; Male; Menopause;

1988

Other Studies

1 other study available for pamidronate and Menopause

ArticleYear
Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:7

    Topics: Adult; Alendronate; Amino Acid Sequence; Antibodies; Biomarkers; Bone Resorption; Collagen; Collagen

1997